Cancer therapeutic targets

In the past decade, we have experienced an explosion of new information about cancer therapeutic targets. Many of the targets have been validated by the discovery and approval of new medicines which have been approved for the treatment of cancer. On the heels of these successes, innumerable new targ...

Full description

Saved in:
Bibliographic Details
Other Authors Marshall, John L. (Editor)
Format Electronic eBook
LanguageEnglish
Published New York, NY : Springer, 2017.
Subjects
Online AccessPlný text

Cover

Loading…

MARC

LEADER 00000cam a2200000Ii 4500
001 97268
003 CZ-ZlUTB
005 20210401194821.0
006 m o d
007 cr cnu|||unuuu
008 170413s2017 nyua fo 001 0 eng d
999 |c 97268  |d 97268 
020 |a 9781461466130  |q (electronic book : living reference work) 
020 |a 9781441907172  |q (electronic bk.) 
020 |a 9781441907189  |q (print and electronic bundle) 
020 |z 9781441907165  |q (print) 
024 7 |a 10.1007/978-1-4419-0717-2  |2 doi 
035 |a (OCoLC)982246723  |z (OCoLC)1096757482  |z (OCoLC)1097045793 
040 |a GW5XE  |b eng  |e rda  |e pn  |c GW5XE  |d OCLCF  |d YDX  |d UAB  |d MERER  |d AZU  |d ESU  |d IOG  |d OCLCQ  |d VT2  |d COO  |d AUD  |d OTZ  |d NJR  |d JG0  |d U3W  |d CAUOI  |d COS  |d COF  |d W2U  |d UWW  |d KSU  |d AU@  |d WYU  |d OCLCQ  |d YDXIT  |d OCLCQ  |d GW5XE  |d UBY  |d EBLCP 
072 7 |a 616  |x Patologie. Klinická medicína  |2 Konspekt  |9 14 
080 |a 616-006.04  |2 MRF 
080 |a 001.891  |2 MRF 
080 |a 616-074/-079  |2 MRF 
080 |a 616.1/.6  |2 MRF 
080 |a 577.2  |2 MRF 
080 |a 615.01/.09  |2 MRF 
080 |a (0.034.2:08)  |2 MRF 
080 |a (082)  |2 MRF 
245 0 0 |a Cancer therapeutic targets /  |c John L. Marshall, editor. 
264 1 |a New York, NY :  |b Springer,  |c 2017. 
300 |a 1 online resource :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
500 |a Includes index. 
506 |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty 
520 |a In the past decade, we have experienced an explosion of new information about cancer therapeutic targets. Many of the targets have been validated by the discovery and approval of new medicines which have been approved for the treatment of cancer. On the heels of these successes, innumerable new targets and new potential therapeutics are being developed by many different groups including government agencies, pharmaceutical companies, biotechnology companies, academic institutions, and individual investigators. Understanding the expanding "universe" of cancer therapies is therefore becoming impossible and no single source exists which serves as a reference for the involved parties. Further, the interested parties have vastly different areas of expertise, from focused laboratory based science, to clinical research, to corporate and regulatory oversight. The text would be updated every two years, more often depending on pace of change, interest and sales. While useful online, this reference book would likely be kept in hard copy as well.- Resumé vydavatel 
590 |a SpringerLink  |b Springer Complete eBooks 
650 0 7 |a maligní nádorová onemocnění  |2 czenas  |7 ph170635 
650 0 7 |a vědecký výzkum  |2 czenas  |7 ph116680 
650 0 7 |a onkologie  |2 czenas  |7 ph123742 
650 0 7 |a laboratorní diagnostika  |2 czenas  |7 ph115087 
650 0 7 |a vnitřní lékařství  |2 czenas  |7 ph116595 
650 0 7 |a molekulární biologie  |2 czenas  |7 ph115344 
650 0 7 |a farmakologie  |2 czenas  |7 ph114526 
650 0 9 |a cancer  |2 eczenas 
650 0 9 |a scientific research  |2 eczenas 
650 0 9 |a oncology  |2 eczenas 
650 0 9 |a laboratory diagnostics  |2 eczenas 
650 0 9 |a internal medicine  |2 eczenas 
650 0 9 |a molecular biology  |2 eczenas 
650 0 9 |a pharmacology  |2 eczenas 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
655 7 |a sborníky  |7 fd163935   |2 czenas 
655 9 |a electronic books  |2 eczenas 
655 9 |a papers of several authors  |2 eczenas 
700 1 |a Marshall, John L.  |q (John Lindsay),  |e editor. 
776 0 |z 1441907181 
856 4 0 |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-1-4419-0717-2  |y Plný text 
942 |2 udc 
992 |c NTK-SpringerBLS